MedTech Industry Dynamics
MedTech Industry Dynamics
TE Connectivity heeft een nieuw geautomatiseerd 3D-printproces geïntroduceerd voor de vervaardiging van katheterschachten dat een duurder handmatig assemblageproces vervangt, snellere ontwerpiteratie mogelijk maakt en mogelijk de productkosten voor fabrikanten van medische hulpmiddelen verlaagt.
Meer lezenCroíValve has closed a $20 million Series B expansion financing round, combined with $7 million in grant funding, to support an expanded TANDEM II study evaluating its DUO Adapt System for tricuspid regurgitation.
Meer lezenMedtronic has announced the establishment of a European software development hub in Galway for its Patient Care Systems function, creating 85 initial roles and serving as a global centre of excellence for cardiac digital health to support patients with implanted cardiac devices.
Meer lezenThe investment will fund purpose-built laboratories to support next-generation technology development across structural heart, cardiovascular, endoscopy, heart failure, and renal denervation, reinforcing Galway’s role as a global medtech hub.
Meer lezenUniversity of Galway has launched a new Medical Device Prototype Hub with Medtronic, strengthening research, prototyping, and early-stage innovation capabilities within Ireland’s MedTech ecosystem.
Meer lezenSiemens Healthineers has opened a €10 million immunoassay R&D centre in Swords, Ireland, strengthening its laboratory diagnostics development capabilities and expanding high-skilled engineering roles.
Meer lezenHaemonetics has acquired Ireland-based Vivasure Medical in a deal valued up to €185 million, adding a fully bioresorbable vascular closure technology as it expands its footprint in structural heart and endovascular procedures.
Meer lezenCardiacBooster secures major Irish government funding to develop its mechanical cardiac support device for treating cardiogenic shock.
Meer lezenPerfuze has received FDA 510(k) clearance for its Zipline™ Access Catheters, designed to simplify and enhance stroke treatment. The company also secured €22 million in funding to support the Limited Market Release of Zipline™ and Millipede™ catheters, advancing its mission to improve stroke care through innovative neurovascular technologies.
Meer lezenFIRE1 heeft 120 miljoen dollar aan financiering veiliggesteld en heeft van de FDA de aanduiding 'Breakthrough Device' ontvangen voor zijn Norm™-systeem, dat bedoeld is om het beheer van hartfalen te transformeren door patiëntenzelfzorg te bevorderen.
Meer lezen
